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INTRODUCTION 
 
Quantifying the nuclear DNA (nDNA) methylation of 
cytosine bases at specific autosomal genetic loci has 
been widely used to estimate an individuals age for 
forensic and medical purposes [1-5]. The existence of 
methylated cytosines within mtDNA has been 
controversial. Originally proposed four decades ago, 
the presence of mitochondrial methylation has been 
difficult to confirm [6, 7]. Maekawa et al. showed 
signals for mitochondrial methylation in 2004, [8] and 
Infantino and co-workers provided the first evidence 
of methylated bases (5-methyl-2ƍ-deoxycytidine) 
present in human mtDNA using mass spectrometry[9]. 
MtDNA methylation has now been reported in the 
form of methylcytosine (mC) and hydro-
xymethylcytosine (hmC) modification[10], and a 
mitochondrially targeted DNA methyltransferase 1 
enzyme (mtDNMT1) is suggested to be 
responsible[11, 12, 13, 14-18]. 
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MtDNA methylation has been proposed as a cause of 
ageing and disease [13, 19, 20]. A comprehensive 
profile of methylation levels across the mitochondrial  
genome and across ages would be an invaluable 
starting-point to address the role of epigenetics in these 
biological phenomena. Here, we describe the next 
generation sequencing analysis of blood-derived, 
bisulphite-treated mtDNA taken from a cohort of 
subjects with ages ranging from 18 to 91, using the 
Illumina MiSeq sequencing platform. 
 
We selected functional regions of interest (ROI) within 
the mitochondrial genome and designed primers for 
methylation analysis  for example, the displacement 
loop (D-loop)/hypervariable regions that contain the 
promoters for the heavy and light strand 
polycistronic mRNAs, specific mitochondrial genes, 
and regions where published evidence already exists for 
methylation. [12] In addition, two replicated sites of 
mtDNA mutation were chosen because of their potential 
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to create or destroy CpG dinucleotides: an A11778G 
associated with Leber`s Heriditary Optic Neuropathy, 
[21] and a T8993G mutation, which is associated with a 
neurological phenotype [22, 23]. 
 
RESULTS  
 
The mitochondrial genome sequence (GRCH38 or 
Anderson/Cambridge reference sequence) [24] consists 
of 16,565 bp in which 435 predicted CpG sites are 
present (Supplementary 1). We used bisulphite treatment 
and high-throughput sequencing (Illumina) to assess 
methylation levels within regions of interest chosen 
because of their functional importance within the mito-
chondrial genome. In total the study queried methylation 
levels at 133/435 CpG sites in the first sample set of 
DNA from 41 individuals. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
We identified unambiguous evidence for non-zero 
mtDNA methylation at 54 of the 133 CpG sites 
sequenced with average read depth of 2000 (Fig. 1). 
Methylation levels were, on average, very low (often 
between 2-6%) but showed regional differences across 
the mitochondrial genome and, more importantly, a 
great variance between individuals, as the methylation 
maxima and averages indicate (Fig.1). 
 
The correlation between methylation and age was 
determined in the data set sample using Pearsons 
correlation coefficient for the 54 sites. Sites MT1215 and 
MT1313, both in the 12S RNA gene (MT-RNR1) showed 
significant methylation changes (hypomethylation) with 
increasing age (MT1215, R=-0.322 p=0.043. mt1313 R=-
0.383, p=0.015). These findings were consistent with 
age-related changes reported in the general 12S RNA 
gene region by others [13, 26] . 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure2.Methylationlevels(expressedasafraction)attwoCpGsiteswithinthe12SRNAgene,M1215(a)andM1313
(b),correlatewithageandcanbeusedtoconstructanaccuratepredictivemodel(c)usingPearsonscorrelation.
Figure 1. Mean methylation levels at 54 CpG sites across the mitochondrial genome (category labels denote
referencebaseposition).Whilemethylation levelsare typically2 ?6%, considerable inter ?individual variationwas
observed,indicatedbyminimumandmaximumrangebars.CpGsiteswithinthe12SRNAgenearehighlighted.
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In the next step, multivariate linear regression was 
applied to the methylation data from both M1215 and 
M1313 (Fig.2a, b) and a linear regression prediction 
model was developed relating age to methylation. 
 
The prediction accuracy of the model and contribution 
of particular predictors were assessed using the adjusted 
R
2
 statistic, which measures the proportion of age 
variation explained by the developed model. The model 
yielded an R
2
=0.509 indicating that 50% of the 
variation in methylation could be explained by age. The 
mean absolute deviation (MAD) between predicted and 
chronological age was 9.3 years (Fig.2c).  
 
The second sequenced library dataset (n=41 individuals) 
was used to evaluate the model. From this set, 31 
samples (64.5%) had ages correctly predicted to within 
a ± MAD. The analysed samples were also divided into 
three age categories: I: 1839 years, II: 4059 years, III: 
60 years and older. Prediction results were significantly 
better for samples from category II (83.3% correct 
predictions) than for categories I (53.8%) and III (20% 
correct predictions), suggesting that innate or 
environmental methylation-determining factors, in 
addition to age, are at play in early and late life. 
 
DISCUSSION 
 
Although previous reports have shown correlation of 
mtDNA damage and mutation with aging, [27]  it was 
only very recently that studies suggested that 
mitochondrial methylation could be used as an ageing 
biomarker [13, 15, 28]. Dzitoyeva and co-workers have 
reported the existence of mitochondrial DNA 
(hydroxy)methylation and its increase with ageing in 
subregions the mouse brain.[10] Our study provides the 
most comprehensive map of methylation levels at 133 
of the available 435 CpG sites in the mitochondrial 
genome from 82 individuals. Quantified changes in the 
methylation state (hypomethylation) of two 12S RNA 
gene CpG sites (M1215 and M1313) correlate with age. 
This novel discovery opens new avenues to investigate 
the mtDNA changes associated with health status and in 
the processes of criminal investigation. The CpG pair at 
M1215 and M1313 could only have been detected 
using high throughput sequencing, such as by Illumina 
MiSeq300 v2. Therefore, such sensitive and advanced 
methodologies can solve the issue of failure to detect 
low-level methylation in the mtDNA genome that may 
explain reported absence of mitoepigenetics [29, 30], its 
failure as a health tool marker [8] or its description as 
having an unusual CpG pattern.[14] Also contributing 
to this confusion might have been the use of 
quantification techniques such as ELISA and MeDIP 
that may struggle with low-level methylation. 
The correlation between M1215/M1313 methylation 
and age was especially accurate for younger and 
middle-aged individuals in contrast to the poorer 
predictive power after the age of 60. This might reflect 
differences in individual lifetime metabolic health or 
exposure to environmental influences, thus giving rise 
to discrepancies between biological and chronological 
age. Furthermore, we speculate that these life-
accumulated environmental influences cause the 
substantial general mtDNA methylation variance 
observed between individuals. Alternatively, 
methylation differences might also reflect varying 
representation of cell-types in blood samples  again, a 
potential surrogate for cytological investigation that 
might provide useful insights into immunological status.  
Our study did not differentiate between 5mC and 5hmC 
as the chemical conversion by sodium bisulphite (the 
gold standard detection technique for methylation 
studies) distinguishes only converted cytosines from 
non-methylated cytosines. The study has some 
limitations that have been taken into account in data 
interpretation.  Further studies are needed to isolate 
mtDNA and analyse its methylation in specific subtypes 
of blood cells, such as platelet progenitors and 
lymphocytes. Further, mitochondrial DNA analysis 
from other populations and from male samples needs to 
be carried out to assess the generality of our findings. 
Lastly, the impact on mtDNA methylation of 
determinants of ill health, including smoking, pollution, 
obesity and chronic life stress should be studied to 
quantify external influences. 
 
To conclude, Illumina sequencing of 82 human blood 
samples indicated clear methylation patterns in mtDNA 
at 54 CpG sites in mitochondrial genome and that the 
level of the methylation was variable among different 
ages (18-91 years). Two of these CpG sites (M1215 and 
M1313) showed stronger correlation between predicted 
and chronological age with only about 9 years mean 
absolute difference (MAD). This finding implies that 
mtDNA methylation will be an available biological 
marker for forensic age-prediction and health status 
measurement. 
 
PATIENTS, MATERIALS AND METHODS 
 
Samples. The project was approved by the University of 
Strathclyde Ethics Committee and, prior to sample 
collection, participants signed an informed consent 
statement. A qualified phlebotomist took 5ml blood 
samples from 82 female volunteers (age 18-91 yrs) at 
Erbil Hospital, Iraq. All the volunteers were from the 
Kurdish ethnic group but were recruited randomly 
without any health history or background information 
on education, marriage status, BMI, smoking, parity or 

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lifestyle. 100 µL aliquots were immediately placed in 
Eppendorf tubes and DNA extracted. The extracted 
DNA was quantified by Stratagene 3005X qPCR 
instrument (Agilent Technologies, CA, USA), using the 
Quantifiler® Human DNA Quantification Kit cat. # 
4343895 (Life Technologies, CA, USA).  
 
Region of interest selection. The mitochondrial 
sequence (GRCH38 or Anderson/Cambridge reference 
sequence) [24]
 
consists of 16,565 bp in which 435 
predicted CpG sites are present (Supplementary 1).  
Regions of interest (ROI) were chosen on the basis of 
biological function: the promoters for both heavy and 
light strand of the D-loop regions, polycistronic 
mRNAs and most of the functional genes of 
mitochondria. In  addition,  two  replicated  sites  site  of  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
mtDNA mutation were chosen because of their potential 
to create or destroy CpG dinucleotide: A11778G 
associated with Leber`s Heriditary Optic Neuropathy, 
[21] and a T8993G mutation, which is associated with a 
neurological phenotypes [22, 23].  Primer sequences 
used to amplify the RsOI (each amplicon 100-300bp in 
length) and the amplicon sequence (before and after 
bisulphite conversion) are in Supplementary 2. Primers 
targeting 10 ROI amplicons (Table 1) were designed 
using Methyl Primer Express Software v1.0 (Applied 
Biosystem, Foster City, California), synthesised 
(Applied Biosystems, Foster City, California, and Life 
Technologies, CA, USA), and successfully passed 
amplification quality control criteria. Some locations 
within each ROI were impossible to amplify due to 
repeat sequences or high CpG content. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table1.10AmpliconswhichpassedIlluminaqualitycontrolcriteria.ThelocationofeachROIin
mitochondriagenome(ChrM)andestimatedampliconnumberinthemDNAareshownaswell.
 
ROI Location Estimated number 
of amplicons 
Promoter (+) ChrM:141-700 1 
Promoter (-) ChrM:544,525-624 1 
12s Ribosomal RNA ChrM:501-1700 1 
Origin of light strand ChrM:5541-6040 1 
Cytochrome C oxidative subunit1 ChrM:5541-6040 1 
Cytochrome C oxidative subunit2 ChrM:5781-6340 2 
Cytochrome C oxidative subunit3 ChrM:=9141-9940 1 
MT-ND6 ChrM:=14001-14740 1 
T8993G ChrM:=8781-9160 1 
G11778A ChrM:11541-12040 1 
Total  10 

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Bisulphite analysis and library construction. The mtDNA 
was modified (non-methylated C residues converted to 
U) via a bisulphite conversion step, EZ DNA 
Methylation-DirectTM Kit (Cat. 5020 and 5021, Zymo 
Research).[25] Multiplex PCR amplification of the RsOI 
(Fluidigm Access ArrayTM System, BioMark, USA) 
generated pools of amplicons that also employed a 
universal forward tag common sequence 1 (CS1), and 
universal reverse tag common sequence 2 (CS2) (CS1= 
5'-ACACTGACGACATGGTTCTACA-3', CS2 = 5'-
TACGGTAGCAGAGACTTGGTCT-3'). Each indivi-
dual amplicon pool was subsequently barcoded. Two 
age-matched libraries, each consisting of 41 individuals, 
were created and purified (ZR-96 DNA Clean & 
Concentrator - ZR, Cat.# D4023) and then prepared for 
massively parallel sequence by Illumina next generation 
sequencing (NGS) using a MiSeq V2 300bp Reagent Kit 
(cat. # MS-102-2001), (paired-end sequencing protocol) 
according to the manufacturers guidelines.  
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SUPPLEMENTARY DATA 

Please browse the Full text version of this manuscript to 
see the Supplementary material. 
 
Supplementary 1. The regions of interest (ROI) with 
their sequences and primer sequences (forward and 
reverse). The single strand sequences of the ROI after 
bisulphite sodium conversion with the primers sequence 
(forward and reverse).  
 
Supplementary 2. Reference Sequence: The Mito-
chondrial sequence (hg38:2013) shows all the 345 CG 
(underlined and bold CG) and 54 assessed sites 
indicated by red text with underlined and bold CG. 
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